- Markets
- Healthcare
- ISHITADR
ISHITADR
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Ishita Drugs & Inds. do?
Ishita Drugs & Industries Ltd, a leading company of the 'Ishita' Group, specializes in manufacturing Active Pharma Ingredients, drug intermediates, excipients, and fine chemicals with a focus on quality and environmental safety.
Who are the competitors of Ishita Drugs & Inds.?
Ishita Drugs & Inds. major competitors are Adeshwar Meditex, Kabra Drugs, Zenith Health Care, Chemo Pharma Labs, Phaarmasia, Hamps Bio, Emmessar Biotech&Nut. Market Cap of Ishita Drugs & Inds. is ₹24 Crs. While the median market cap of its peers are ₹20 Crs.
Is Ishita Drugs & Inds. financially stable compared to its competitors?
Ishita Drugs & Inds. seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Ishita Drugs & Inds. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ishita Drugs & Inds. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ishita Drugs & Inds. allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Ishita Drugs & Inds. balance sheet?
Balance sheet of Ishita Drugs & Inds. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Ishita Drugs & Inds. improving?
Yes, profit is increasing. The profit of Ishita Drugs & Inds. is ₹0.86 Crs for TTM, ₹0.75 Crs for Mar 2024 and ₹0.58 Crs for Mar 2023.
Is the debt of Ishita Drugs & Inds. increasing or decreasing?
Yes, The debt of Ishita Drugs & Inds. is increasing. Latest debt of Ishita Drugs & Inds. is -₹4.22 Crs as of Sep-24. This is greater than Mar-24 when it was -₹9.25 Crs.
Is Ishita Drugs & Inds. stock expensive?
Yes, Ishita Drugs & Inds. is expensive. Latest PE of Ishita Drugs & Inds. is 27.75, while 3 year average PE is 23.35. Also latest EV/EBITDA of Ishita Drugs & Inds. is 19.7 while 3yr average is 15.29.
Has the share price of Ishita Drugs & Inds. grown faster than its competition?
Ishita Drugs & Inds. has given better returns compared to its competitors. Ishita Drugs & Inds. has grown at ~15.39% over the last 3yrs while peers have grown at a median rate of -1.0%
Is the promoter bullish about Ishita Drugs & Inds.?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 49.91% and last quarter promoter holding is 49.85%.
Are mutual funds buying/selling Ishita Drugs & Inds.?
There is Insufficient data to gauge this.